{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:10:55Z","timestamp":1793398255142,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamapsychiatry.2021.0042","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T16:32:50Z","timestamp":1615393970000},"page":"632","source":"Crossref","is-referenced-by-count":116,"title":["Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia"],"prefix":"10.1001","volume":"78","author":[{"given":"T. Scott","family":"Stroup","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute for Health, Health Care Policy and Aging, Rutgers University, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M.","family":"Wall","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davangere P.","family":"Devanand","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"},{"name":"New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gerhard","sequence":"additional","affiliation":[{"name":"Institute for Health, Health Care Policy and Aging, Rutgers University, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"yoi210003r2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"yoi210003r3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s disease facts and figures.","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"8","key":"yoi210003r4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease.","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"yoi210003r5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/appy.2016.8.issue-2","article-title":"Higher prevalence of dementia in patients with schizophrenia: a nationwide population-based study.","volume":"8","author":"Ku","year":"2016","journal-title":"Asia Pac Psychiatry"},{"issue":"11","key":"yoi210003r6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamapsychiatry.2015.1546","article-title":"Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study.","volume":"72","author":"Ribe","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi210003r7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/acp.1999.100.issue-3","article-title":"Dementia in affective disorder: a case-register study.","volume":"100","author":"Kessing","year":"1999","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"yoi210003r8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1567205011666140812115004","article-title":"Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65-84 years): a population based case-control study.","volume":"11","author":"Zilkens","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"yoi210003r9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2018.05.005","article-title":"Increased risk of dementia in patients with schizophrenia: a population-based cohort study in Taiwan.","volume":"53","author":"Lin","year":"2018","journal-title":"Eur Psychiatry"},{"issue":"7","key":"yoi210003r10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/0164027517728554","article-title":"Estimating the prevalence of serious mental illness and dementia diagnoses among Medicare beneficiaries in the Health and Retirement Survey.","volume":"40","author":"Brown","year":"2018","journal-title":"Res Aging"},{"issue":"3","key":"yoi210003r11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","article-title":"Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.","volume":"55","author":"Purohit","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi210003r12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"issue":"1","key":"yoi210003r13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/JCP.0000000000000058","article-title":"Body mass index, obesity, and psychopathology in patients with schizophrenia.","volume":"34","author":"Subramaniam","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"yoi210003r14","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/schbul\/sbm140","article-title":"Is schizophrenia a syndrome of accelerated aging?","volume":"34","author":"Kirkpatrick","year":"2008","journal-title":"Schizophr Bull"},{"key":"yoi210003r15","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2147\/NDT","article-title":"Schizophrenia and risk of dementia: a meta-analysis study.","volume":"14","author":"Cai","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"yoi210003r16","first-page":"69","article-title":"Accuracy of diagnoses of schizophrenia in Medicaid claims.","volume":"43","author":"Lurie","year":"1992","journal-title":"Hosp Community Psychiatry"},{"issue":"9","key":"yoi210003r18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0895-4356(02)00452-3","article-title":"The accuracy of Medicare claims data in identifying Alzheimer\u2019s disease.","volume":"55","author":"Taylor","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"yoi210003r19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jns.2004.11.022","article-title":"Survival following dementia onset: Alzheimer\u2019s disease and vascular dementia.","volume":"229-230","author":"Fitzpatrick","year":"2005","journal-title":"J Neurol Sci"},{"issue":"9503","key":"yoi210003r20","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study.","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"yoi210003r21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1176\/appi.ps.201700356","article-title":"Psychotropic medication use among adults with schizophrenia and schizoaffective disorder in the United States.","volume":"69","author":"Stroup","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"5","key":"yoi210003r22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","article-title":"Is there really a link between benzodiazepine use and the risk of dementia?","volume":"14","author":"Billioti de Gage","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"yoi210003r23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: a meta-analysis.","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"issue":"3-4","key":"yoi210003r24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis.","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"9831","key":"yoi210003r25","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"yoi210003r26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/schbul\/sbu164","article-title":"Antipsychotic treatment and mortality in schizophrenia.","volume":"41","author":"Torniainen","year":"2015","journal-title":"Schizophr Bull"},{"issue":"9","key":"yoi210003r27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"yoi210003r29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.schres.2017.05.009","article-title":"Cognitive and functional deficits in people with schizophrenia: evidence for accelerated or exaggerated aging?","volume":"196","author":"Harvey","year":"2018","journal-title":"Schizophr Res"},{"key":"yoi210003r31","article-title":"Toolkit for assessing and addressing cognitive health in early psychosis: evaluation of feasibility and utility in a coordinated specialty care setting.","author":"Saperstein","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"yoi210003r32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/0019-5545.58904","article-title":"What is schizophrenia: a neurodevelopmental or neurodegenerative disorder or a combination of both? a critical analysis.","volume":"52","author":"Gupta","year":"2010","journal-title":"Indian J Psychiatry"},{"issue":"9","key":"yoi210003r33","doi-asserted-by":"publisher","first-page":"e1284","DOI":"10.4088\/JCP.17m11523","article-title":"Anticholinergic burden and cognition in older patients with schizophrenia.","volume":"78","author":"Tsoutsoulas","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"yoi210003r34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/01.wnl.0000310773.65918.cd","article-title":"Prevalence of dementia after age 90: results from the 90+ study.","volume":"71","author":"Corrada","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"yoi210003r35","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jamapsychiatry.2015.1745","article-title":"Dementia in patients with schizophrenia: evidence for heterogeneity.","volume":"72","author":"Lyketsos","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"yoi210003r1","volume-title":"The Global Burden of Disease","author":"World Health Organization","year":"2008"},{"key":"yoi210003r28","author":"Linkins","year":"2001"},{"key":"yoi210003r17","unstructured":"Chronic Conditions Data Warehouse. Condition categories. Accessed August 21, 2020. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories"},{"key":"yoi210003r30","unstructured":"Janssen Pharmaceutical Companies. Risperdal (risperidone) [package insert]. US Food and Drug Administration website. Revised January 2019. Accessed February 4, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020272s082,020588s070,021444s056lbl.pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2777006\/jamapsychiatry_stroup_2021_oi_210003_1622231730.75199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T16:14:49Z","timestamp":1622650489000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2777006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0042","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}